Cord Blood America Inc.  

(Public, OTCMKTS:CBAI)   Watch this stock  
Find more results for OTC:CBAI
-0.0001 (-3.85%)
Delayed:   11:14AM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 0.00
Open 0.00
Vol / Avg. 1.38M/4.11M
Mkt cap 2.22M
P/E     -
Div/yield     -
EPS -0.01
Shares 890.00M
Beta 3.09
Inst. own 1%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -39.79% -39.96%
Operating margin -17.01% -20.76%
EBITD margin - -7.54%
Return on average assets -37.06% -34.95%
Return on average equity - -
Employees 15 -
CDP Score - -


17888 67TH N CT
United States - Map
+1-702-9147250 (Phone)

Website links


Cord Blood America, Inc. (CBAI) is a holding company. CBAI is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services. CBAI�s wholly owned subsidiaries include Cord Partners, Inc., CorCell Companies. Inc., CorCell Ltd., (Cord), CBA Professional Services, Inc. doing business as (D/B/A) BodyCells, Inc. (BodyCells), CBA Properties, Inc. (Properties), and Career Channel Inc D/B/A Rainmakers International (Rain). The Properties was formed to hold the corporate trademarks and other intellectual property. On February 24, 2011, the Company acquired 593 umbilical cord blood samples and all related file documents, four cryogenic storage tanks, and two computers from Reproductive Genetics Institute, Inc. (RGI). In October 2012, it sold its 51% stake in stellacure, GmbH (stellacure) to Medivision mbH.

Officers and directors

Joseph R. Vicente Chairman of the Board, President
Age: 50
Stephen David Morgan Vice President, Secretary
Age: 36
Timothy G. McGrath Independent Director
Age: 49